Chemoradiation paradigm for the treatment of lung cancer

For the treatment of advanced non-small-cell lung cancer, randomized controlled trials have shown that platinum-based chemotherapy and radiotherapy provide a measurable survival benefit compared with radiotherapy alone. Newer drugs that target growth factor receptors might further synergize with ion...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature clinical practice. Oncology 2006-04, Vol.3 (4), p.188-199
Hauptverfasser:	Eberhardt, Wilfried, Pöttgen, Christoph, Stuschke, Martin
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Carboplatin Carboplatin - administration & dosage Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - radiotherapy Care and treatment Chemoradiotherapy Chemotherapy Cisplatin Cisplatin - administration & dosage Clinical trials Clinical Trials, Phase III as Topic Combined Modality Therapy Diagnosis Etoposide - administration & dosage Gemcitabine Health aspects Humans Lung cancer Lung Neoplasms - drug therapy Lung Neoplasms - radiotherapy Medicine Medicine & Public Health Metastases Methods Multicenter Studies as Topic Oncology Paclitaxel - administration & dosage Radiation therapy Radiotherapy Randomized Controlled Trials as Topic review-article Synergism Taxanes Toxicity Vinorelbine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!